Jianfeng Group 2011 Annual Profit Distribution Implementation Announcement
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviations: Jianfeng Group Announcement Number: pro 2012-012
Zhejiang Jianfeng Group Co., Ltd. 2011 Annual Profit Distribution Implementation Announcement
The Company and all members of the Board of Directors guarantee that there are no false records, misleading statements or major omissions in the contents of the announcement, and shall bear individual and joint liabilities for the truthfulness, accuracy and completeness of its contents.
Important Content Note:
● Cash Dividend Per Share Before and After Tax Deduction Units: yuan
Cash Dividend Per Share (Before Tax Deduction) 0.120
Cash Dividend Per Share (After Tax Deduction) 0.108
● Equity Registration Date
Equity Registration Date 2012 6 29
● Ex-rights (ex-dividend) date: 2012 7 2
● cash dividend payment date
cash dividend payment date 2012 7 August 6 day
1. Number and Time of Shareholders' Meeting Passed Distribution and Capital Transfer Plan
Zhejiang Jianfeng Group Co., Ltd. 2011 Annual Profit Distribution Plan Through 2012 5 # November April 8 the company's 2011 annual shareholders' meeting held on
was reviewed and approved. The announcement of the resolution of the shareholders' meeting was published in 2012 5 March 9 on the websites of china securities journal, shanghai securities news and Shanghai Securities Exchange Exchange.
2. Distribution and Transfer of Shares Plan
(I) Distribution Year: 2011 Year
( 2 ) Distribution Scope:
Deadline 2012 6 July 29 All shareholders of the Company registered in Shanghai Branch of China Securities Depository and Clearing Corporation Limited after closing on the afternoon of Shanghai Stock Exchange.
( 3 ) This distribution is based on ,083, 828 shares, and a cash dividend of 1.2 # (tax included) is distributed to all shareholders for every 10 shares, after tax deduction,
will distribute cash dividend 1.08 yuan per 10 shares, totaling 41,290,059.36 yuan.
3. implementation date
(I) equity registration date
equity registration date 2012 year 6 March 29 day
( 2 ) ex-rights (ex-dividend) day: 2012 7 January 2
( 3 ) Cash Dividend Payment Date
Cash Dividend Payment Date July 6, 2012
4. Distribution object
Deadline 2012 6 April 29 (A Share Registration Date) After the Shanghai Stock Exchange closes in the afternoon, all shareholders registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd.
Implementation Measures for 5. Dividends and Capital Increases
1. The cash dividends of Jinhua Tongji State-owned Assets Investment Co., Ltd., a shareholder of the Company, shall be directly distributed by the Company.
2 , the cash dividends of other shareholders of the company except Jinhua Tongji State-owned Assets Investment Co., Ltd., the company entrusts China Securities Depository and Clearing Corporation Shanghai Branch to share rights through its fund clearing system Distribute to shareholders registered on the registration date. Investors who have handled comprehensive designated transactions can receive cash dividends at their designated securities business department on the dividend payment date. Shareholders' dividends that have not handled designated transactions are temporarily kept by the Shanghai Branch of China Securities Depository and Clearing Corporation, and will be distributed after the designated transactions are processed. 3 , dividends for individual shareholders, qualified foreign institutional investors (QFII ) and securities investment funds shall be withheld by the company at a tax rate of 10% of to pay income tax, and the cash dividend after tax shall be 0.108 yuan per share. For the dividends of other institutional investors and corporate shareholders, they shall pay their own income tax. The cash dividend distributed this time is 0.12 yuan per share.
6. Relevant Consultation Measures
1 , Address: Office of the Board of Directors of Jianfeng Building, 88 , Wujiang East Road, Jinhua City, Zhejiang Province
2 , Tel: 0579-82320582 ; Fax: 0579-82324666
7. Reference Document Catalog
Company 2011 Annual General Meeting Resolution and Announcement.
Zhejiang Jianfeng Group Co., Ltd.
Date: 2012 6 26
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page